PGNYProgyny, Inc.

Nasdaq progyny.com


$ 24.72 $ 0.22 (0.92 %)    

Tuesday, 17-Sep-2024 15:39:46 EDT
QQQ $ 472.46 $ -3.51 (-0.74 %)
DIA $ 416.64 $ -1.35 (-0.32 %)
SPY $ 562.06 $ -3.07 (-0.54 %)
TLT $ 100.92 $ -0.47 (-0.46 %)
GLD $ 237.39 $ -0.59 (-0.25 %)
$ 24.31
$ 24.50
$ 24.71 x 100
$ 24.75 x 100
$ 24.50 - $ 25.37
$ 19.60 - $ 42.08
1,471,357
na
2.19B
$ 1.31
$ 34.97
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-04-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-04-2022 09-30-2022 10-Q
9 08-05-2022 06-30-2022 10-Q
10 05-06-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-08-2021 09-30-2021 10-Q
13 08-06-2021 06-30-2021 10-Q
14 05-07-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 11-06-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-14-2020 03-31-2020 10-Q
19 03-10-2020 12-31-2019 10-K
20 12-06-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- Reuters

 cantor-fitzgerald-reiterates-overweight-on-progyny-maintains-37-price-target

Cantor Fitzgerald analyst Sarah James reiterates Progyny (NASDAQ:PGNY) with a Overweight and maintains $37 price target.

 jp-morgan-maintains-overweight-on-progyny-lowers-price-target-to-31

JP Morgan analyst Anne Samuel maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $41 to $31.

 btig-downgrades-progyny-to-neutral

BTIG analyst David Larsen downgrades Progyny (NASDAQ:PGNY) from Buy to Neutral.

 jmp-securities-maintains-market-outperform-on-progyny-lowers-price-target-to-31

JMP Securities analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and lowers the price tar...

 cantor-fitzgerald-maintains-overweight-on-progyny-lowers-price-target-to-37

Cantor Fitzgerald analyst Sarah James maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $48...

 truist-securities-maintains-buy-on-progyny-lowers-price-target-to-33

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and lowers the price target from $37 to...

 canaccord-genuity-downgrades-progyny-to-hold-lowers-price-target-to-24

Canaccord Genuity analyst Richard Close downgrades Progyny (NASDAQ:PGNY) from Buy to Hold and lowers the price target from $...

 leerink-partners-downgrades-progyny-to-market-perform-lowers-price-target-to-25

Leerink Partners analyst Michael Cherny downgrades Progyny (NASDAQ:PGNY) from Outperform to Market Perform and lowers the pr...

 progyny-q2-2024-adj-eps-043-beats-017-estimate-sales-30409m-miss-30542m-estimate

Progyny (NASDAQ:PGNY) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.17 by 152....

 jmp-securities-initiates-coverage-on-progyny-with-market-outperform-rating-announces-price-target-of-36

JMP Securities analyst Constantine Davides initiates coverage on Progyny (NASDAQ:PGNY) with a Market Outperform rating and a...

 progyny-reports-acquisition-of-berlin-based-fertility-benefits-platform-apryl-no-terms-disclosed

This acquisition enhances Progyny's guided, concierge support that enables employees around the world to navigate the compl...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION